Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Placebo|BIOLOGICAL: Denosumab|DRUG: Non-steroidal aromatase inhibitor therapy|DRUG: Zoledronic Acid|OTHER: Standard of Care
Sponsor: Amgen
Collaborators: Austrian Breast and Colorectal Cancer Study Group